2026 Annual Meeting | C104 - En Español: Actualizaciones en el tratamiento de trastornos neuromusculares (Updates in Treatment of Neuromuscular Disorders)
| 01:00 PM - 01:10 PM CDT | Introduction |
Introduction
Rocio C. Garcia Santibanez, MD, FAAN |
| 01:10 PM - 01:40 PM CDT | Speaker |
Update in treatment of neuropathies
Rocio Vazquez Do Campo, MD |
| 01:40 PM - 02:10 PM CDT | Speaker |
Update in the treatment of NMJ disorders
J. David Avila, MD |
| 02:10 PM - 02:40 PM CDT | Speaker |
Update in the treatment of other neuromuscular disorders
Rocio C. Garcia Santibanez, MD, FAAN |
| 02:40 PM - 02:55 PM CDT | Q&A |
Discussion/Questions and Answers
Rocio C. Garcia Santibanez, MD, FAAN, J. David Avila, MD, Rocio Vazquez Do Campo, MD |
| 02:55 PM - 03:00 PM CDT | Closing Remarks |
Closing Remarks
Rocio C. Garcia Santibanez, MD, FAAN |
| Rocio C. Garcia Santibanez, MD, FAAN | Dr. Garcia Santibanez has nothing to disclose. |
| J. David Avila, MD | Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. |
| Rocio Vazquez Do Campo, MD | Dr. Vazquez Do Campo has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with US Department of Health, vaccine compensation program. |